QSS
ALDX icon

Quantitative Systematic Strategies’s Aldeyra Therapeutics ALDX Stock Holding History

Quantitative Systematic Strategies’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-18,902
Closed -$225K – 457
2021
Q1 		$225K Sell
18,902
-6,573
-26% -$75.7K 0.03% 537
2020
Q4 		$175K Sell
25,475
-17,180
-40% -$121K 0.02% 567
2020
Q3 		$316K Buy
42,655
+5,692
+15% +$36.8K 0.06% 429
2020
Q2 		$154K Buy
+36,963
New +$135K 0.03% 536

Other funds holding ALDX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Quantitative Systematic Strategies's ALDX Position: Q2 2021 in Review

Quantitative Systematic Strategies sold out of Aldeyra Therapeutics (ALDX) in Q2 2021, closing a stake of 18,902 shares — an estimated $225K sold.

Quantitative Systematic Strategies first reported a position in ALDX in Q2 2020 and held it in 4 quarters. The position peaked at $316K in Q3 2020. 136 funds tracked by Wall St. Rank hold ALDX as of Q2 2021.

  • Quantitative Systematic Strategies reported no remaining Aldeyra Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 18,902 Aldeyra Therapeutics shares in Q2 2021, an estimated $225K.
  • Quantitative Systematic Strategies first reported a position in Aldeyra Therapeutics in Q2 2020 and held it in 4 quarters.
  • Quantitative Systematic Strategies's Aldeyra Therapeutics position peaked at $316K in Q3 2020.
  • 136 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q2 2021.

Based on Quantitative Systematic Strategies's 13F filing for Q2 2021, filed 5 Aug 2021.